FRENCH GOVT REACHES NEW DEAL WITH HEALTH SECTOR

17 May 1992

The French government has confirmed its new accord with the medical profession to help control health care costs, and the new agreement will come before the Parliament at the end of this month.

The broad aim of the agreement is said to be to impose a global percentage rate of increase in each year as a limit on spending growth with sanctions for breaches of the limit.

Rates Of Growth Each year, the medical organizations and the three main health insurance funds in the public sector will negotiate a rate of growth envisaged for the following year and national growth rates for each sector of activity such as consultations and visits.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight